These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score. Goliasch G; Silbernagel G; Kleber ME; Grammer TB; Pilz S; Tomaschitz A; Bartko PE; Maurer G; Koenig W; Niessner A; März W Sci Rep; 2017 Jul; 7(1):4700. PubMed ID: 28680124 [TBL] [Abstract][Full Text] [Related]
6. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus. Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896 [TBL] [Abstract][Full Text] [Related]
7. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial. Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528 [TBL] [Abstract][Full Text] [Related]
8. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors. Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356 [TBL] [Abstract][Full Text] [Related]
9. Incremental value of B-type natriuretic peptide for detection and risk reclassification of obstructive coronary artery disease on computed tomography angiography. Kawabe M; Sato A; Hoshi T; Endo M; Yoshida I; Aonuma K J Cardiol; 2017 Apr; 69(4):671-677. PubMed ID: 27443597 [TBL] [Abstract][Full Text] [Related]
10. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study. Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186 [TBL] [Abstract][Full Text] [Related]
12. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease. Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study. Tonkin AM; Blankenberg S; Kirby A; Zeller T; Colquhoun DM; Funke-Kaiser A; Hague W; Hunt D; Keech AC; Nestel P; Stewart R; Sullivan DR; Thompson PL; West M; White HD; Simes J; Int J Cardiol; 2015 Dec; 201():499-507. PubMed ID: 26318511 [TBL] [Abstract][Full Text] [Related]
14. Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease. Kato S; Saito N; Kirigaya H; Gyotoku D; Iinuma N; Kusakawa Y; Iguchi K; Nakachi T; Fukui K; Futaki M; Iwasawa T; Taguri M; Kimura K; Umemura S Heart Vessels; 2016 Jun; 31(6):871-80. PubMed ID: 25904244 [TBL] [Abstract][Full Text] [Related]
15. A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score. Mehta SR; Eikelboom JW; Rao-Melacini P; Weitz JI; Anand SS; Pare G; Budaj A; Pogue J; Fox KA; Yusuf S Can J Cardiol; 2016 Nov; 32(11):1332-1339. PubMed ID: 27062239 [TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. März W; Tiran B; Seelhorst U; Wellnitz B; Bauersachs J; Winkelmann BR; Boehm BO; Clin Chem; 2007 Jun; 53(6):1075-83. PubMed ID: 17446333 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456 [TBL] [Abstract][Full Text] [Related]
18. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study. Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847 [TBL] [Abstract][Full Text] [Related]
19. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071 [TBL] [Abstract][Full Text] [Related]
20. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study). Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]